Minor contribution of mutations at <it>iniA </it>codon 501 and <it>embC-embA </it>intergenic region in ethambutol-resistant clinical <it>Mycobacterium tuberculosis </it>isolates in Kuwait
<p>Abstract</p> <p>Background</p> <p>Ethambutol (EMB) is a first-line drug for the treatment of tuberculosis (TB). Resistance to EMB in <it>Mycobacterium tuberculosis </it>isolates is mediated by mutations in several genes involved in arabinan synthesis nota...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-01-01
|
Series: | Annals of Clinical Microbiology and Antimicrobials |
Online Access: | http://www.ann-clinmicrob.com/content/8/1/2 |